DE2124123A1 - Polynucleotid und Verfahren zu deren Herstellung - Google Patents

Polynucleotid und Verfahren zu deren Herstellung

Info

Publication number
DE2124123A1
DE2124123A1 DE19712124123 DE2124123A DE2124123A1 DE 2124123 A1 DE2124123 A1 DE 2124123A1 DE 19712124123 DE19712124123 DE 19712124123 DE 2124123 A DE2124123 A DE 2124123A DE 2124123 A1 DE2124123 A1 DE 2124123A1
Authority
DE
Germany
Prior art keywords
complex
interferon
molecular weight
units
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19712124123
Other languages
German (de)
English (en)
Inventor
George Peter Hatfield; Tytell Alfred A. Lansdale; Field Arthur Kirk North Wales; Hilleman Maurice Ralph Lafayette Hill; Pa. Lampson (V.St.A.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2124123A1 publication Critical patent/DE2124123A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE19712124123 1970-05-15 1971-05-14 Polynucleotid und Verfahren zu deren Herstellung Withdrawn DE2124123A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3789670A 1970-05-15 1970-05-15

Publications (1)

Publication Number Publication Date
DE2124123A1 true DE2124123A1 (de) 1971-12-02

Family

ID=21896942

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712124123 Withdrawn DE2124123A1 (de) 1970-05-15 1971-05-14 Polynucleotid und Verfahren zu deren Herstellung

Country Status (15)

Country Link
US (1) US3666646A (enExample)
AR (1) AR199872A1 (enExample)
BE (1) BE767190A (enExample)
CA (1) CA985677A (enExample)
DE (1) DE2124123A1 (enExample)
ES (1) ES391016A1 (enExample)
FR (1) FR2100660B1 (enExample)
GB (1) GB1355516A (enExample)
HU (1) HU164639B (enExample)
IE (1) IE35215B1 (enExample)
IL (1) IL36772A0 (enExample)
NL (1) NL7105076A (enExample)
NO (1) NO131754B (enExample)
SU (1) SU421202A3 (enExample)
ZA (1) ZA712259B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113162B1 (en) * 1982-09-16 1989-07-19 Hem Research, Inc. Anti-proliferative action of dsnras on tumor cells
ATE299885T1 (de) 1999-02-15 2005-08-15 Nippon Shinyaku Co Ltd Polynukleotide mit gekürzter kette und verfahren zu ihrer herstellung
CA2587676A1 (en) * 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna
DK1898948T3 (da) * 2005-06-08 2012-04-23 Yisheng Biopharma Singapore Pte Ltd Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
EP2116602A1 (en) 2008-05-07 2009-11-11 Institut Gustave Roussy Combination products for treating cancer
EP2542670A2 (en) 2010-03-05 2013-01-09 President and Fellows of Harvard College Induced dendritic cell compositions and uses thereof
WO2016105274A1 (en) 2014-12-23 2016-06-30 Yisheng Biopharma (Singapore) Pte Ltd A rabies composition comprising pika adjuvant
CA3213217A1 (en) 2021-04-28 2022-11-03 Raphael Darteil Strong potentiation of tlr3 agonists effects using fxr agonists as a combined treatment

Also Published As

Publication number Publication date
ZA712259B (en) 1972-11-29
ES391016A1 (es) 1974-04-01
CA985677A (en) 1976-03-16
IE35215B1 (en) 1975-12-10
IE35215L (en) 1971-11-15
AR199872A1 (es) 1974-10-08
FR2100660A1 (enExample) 1972-03-24
IL36772A0 (en) 1971-07-28
NL7105076A (enExample) 1971-11-17
HU164639B (enExample) 1974-03-28
BE767190A (fr) 1971-11-16
SU421202A3 (ru) 1974-03-25
US3666646A (en) 1972-05-30
NO131754B (enExample) 1975-04-14
GB1355516A (en) 1974-06-05
FR2100660B1 (enExample) 1975-06-06

Similar Documents

Publication Publication Date Title
DE3001585C2 (de) Verfahren zur Herstellung von Interferon Typ I und II
DE69030880T2 (de) Zusammensetzung zur Stimulierung des Immunsystems
DE3689071T2 (de) Immunheilbehandlung.
DE2823987C2 (enExample)
DE3045078A1 (de) Nucleasebestaendiger hydrophiler komplex aus polyriboinosinsaeure, verfahren zu seiner herstellung und verwendung desselben
EP0281679B1 (de) Niedermolekulare Alkalihuminate, Verfahren zur ihrer Herstellung und Verwendung
DE3601136A1 (de) Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
EP0152944A2 (de) Verwendung von Adenosin-Derivaten als Antiallergica und Arzneimittel, die diese enthalten
DE2124123A1 (de) Polynucleotid und Verfahren zu deren Herstellung
DE2514536A1 (de) Verfahren zur reaktivierung von interferon
DE68905994T2 (de) Koloniestimulierungsfaktor-gelatinkonjugate.
DE3434122C2 (enExample)
DE2504331A1 (de) Heptaminol-5'-adenosinmonophosphat und dessen therapeutische verwendung
DE1795553B2 (de) 3 Acyloxy 5 phenyl 3H 1,2 dihydro 1,4 benzodiazepinon (2) derivate Ausscheidung aus 1445412
DE1965431B2 (de) Inosin-Komplexverbindungen und Verfahren zu ihrer Herstellung
DE2064296C2 (de) Verfahren zur Herstellung eines injizierbaren Mittels gegen Viren der Mäuseleukämien
DE2307051B2 (de) Verfahren zum Reinigen von langsamen a - und ß -Glykoproteinen aus Mikrobenkörpern und diese enthaltende pharmazeutische Zusammensetzungen
DE951228C (de) Verfahren zur Stabilisierung eines adrenocorticotropen Praeparates
DE3873115T2 (de) Polypeptid mit antiviraler wirkung, und seine anwendung.
DE3822406A1 (de) Verfahren zur herstellung von nucleinsaeurederivaten und verfahren zur herstellung von diese enthaltenden medizinischen zusammensetzungen
CH639667A5 (de) Verfahren zur herstellung von peptidkomplexen aus dns-haltigen organismen.
DE3700164C2 (enExample)
DE1617659A1 (de) Polynucleotide,welche als die Interferonerzeugung in lebenden tierischen Zellen induzierende Verbindungen wirksam sind
DE960579C (de) Verfahren zur Herstellung eines in der Hitze sterilisierbaren Adrenocorticotropin-Praeparates
DE2025810C3 (de) Verfahren zur Isolierung doppelstrangiger Ribonucleinsäure und diese Verbindung enthaltendes Arzneipräparat

Legal Events

Date Code Title Description
OD Request for examination
8139 Disposal/non-payment of the annual fee